Target intelligence / Profile preview

Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)

Target
Nrf2
Molecular classification
Transcription factor, Cap’n’Collar (CNC) subfamily of basic leucine zipper (bZIP) transcription factors
01

Overview

Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that plays a central role in cellular defense against oxidative and electrophilic stress. It regulates the expression of genes containing antioxidant response elements (AREs), leading to increased production of cytoprotective proteins. Nrf2 influences metabolism, inflammation, autophagy, proteostasis, mitochondrial function, and immune responses. Dysregulation of Nrf2 is implicated in diseases such as cancer, atherosclerosis, and liver injury. Therapeutic strategies are being explored to modulate Nrf2 activity.

Other names
NFE2L2NRF₂NF-E₂-related factor ₂
02

Mechanism of action

Under non-stressed conditions, Keap1 binds to the Neh2 domain on Nrf2, promoting ubiquitination and degradation. Upon oxidative/electrophilic stress, Keap1 is modified/inhibited, releasing Nrf2. Stabilized Nrf2 accumulates/translocates into the nucleus, forms heterodimers with small Maf proteins, binds ARE sequences on DNA promoters, and initiates transcription of cytoprotective/antioxidant/detoxification genes.

03

Biological functions

Antioxidant defenseDetoxificationInflammation modulationMetabolism controlAutophagyMitochondrial functionProteostasisImmune responseRedox homeostasis
04

Disease associations

AtherosclerosisCardiovascular diseaseNon-alcoholic steatohepatitisLiver injuryCancerImmunodeficiency syndromesDevelopmental delayLung squamous cell carcinoma
05

Safety considerations

Excessive Nrf2 activity is implicated in cancer progression/resistance mechanisms.Insufficient Nrf2 activity increases susceptibility to injury/inflammation/metabolic disorders.Systemic antioxidants may have adverse consequences; selective modulation of Nrf2 is being explored.

Beyond the preview

Go deeper on Nuclear factor (erythroid-derived 2)-like 2 (Nrf2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor (erythroid-derived 2)-like 2 (Nrf2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call